Nonalcoholic fatty liver disease in pediatric patients

Journal of Parenteral and Enteral Nutrition

Volumn 36, Issue 1 SUPPL., 2012, Pages

  Sinatra, Frank R ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Life cycle; Liver disease; Obesity; Pediatrics; Research and diseases

Indexed keywords

ALPHA TOCOPHEROL; METFORMIN; PIOGLITAZONE; PLACEBO; URSODEOXYCHOLIC ACID;

CHILDHOOD DISEASE; CHRONIC LIVER DISEASE; CONFERENCE PAPER; DIFFERENTIAL DIAGNOSIS; DRUG MEGADOSE; ENVIRONMENTAL FACTOR; FATTY LIVER; GENETICS; HISTOPATHOLOGY; HUMAN; NONALCOHOLIC FATTY LIVER; OBESITY; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); CHILD; CHRONIC DISEASE; CLINICAL TRIAL (TOPIC); INSULIN RESISTANCE; LIVER CIRRHOSIS; REVIEW;

CHILD; CHRONIC DISEASE; CLINICAL TRIALS AS TOPIC; FATTY LIVER; HUMANS; INSULIN RESISTANCE; LIVER CIRRHOSIS; OBESITY; PREVALENCE;

EID: 84860634853     PISSN: 01486071     EISSN: None     Source Type: Journal    
DOI: 10.1177/0148607111421610     Document Type: Conference Paper

References (18)

1. Daniels SR. Complications of obesity in children and adolescents. Int J Obes. 2009;33:s60-s65.
2. Browning JD, Szczepaniak LS, Dobbins R, et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology. 2004;40:1387-1395.
3. Clark JM, Brancati FL, Diehl AM. The prevalence and etiology of elevated aminotransferase levels in the United States. Am J Gastroenterol. 2003;98:960-967.
4. Strauss RS, Barlow SE, Dietz WH. Prevalence of abnormal serum aminotransferase values in overweight and obese adolescents. J Pediatr. 2000;136:727-733.
5. Schwimmer JB, Deutsch R, Kahen T, et al. Prevalence of fatty liver in children and adolescents. Pediatrics. 2006;118:1388-1393.
6. Moran A, Jacobs DR Jr, Steinberger J, et al. Changes in insulin resistance and cardiovascular risk during adolescence: establishment of differential risk in males and females. Circulation. 2008;117:2361-2368.
7. Romeo S, Kozlitina J, Xing C, et al. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat Genet. 2008;40:1461-1465.
8. Santoro N, Kursawe R, D'Adamo E, et al. A common variant in the patatin-like phospholipase 3 gene (PNPLA3) is associated with fatty liver disease in obese children and adolescents. Hepatology. 2010;52:1281-1290.
9. Pagano C, Soardo G, Esposito W, et al. Plasma adiponectin is decreased in nonalcoholic fatty liver disease. Eur J Endocrinol. 2005;152:113-118.
10. Patton HM, Lavine JE, Van Natta ML, et al. Clinical correlates of histopathology in pediatric nonalcoholic steatohepatitis. Gastroenterology. 2008;135:1961-1971.
11. Vos MB, Barv S, Joshi-Barve S, et al. Cytokeratin 18, as a marker of cell death, is increased in children with suspected nonalcoholic fatty liver disease. J Pediatr Gastroenterol Nutr. 2008;47:481-485.
12. Schwimmer JB, Behling C, Newbury R, et al. Histopathology of pediatric nonalcoholic fatty liver disease. Hepatology. 2005;42: 641-649.
13. Nobili V, Manco M, Raponi M, et al. Case management in children affected by non-alcoholic fatty liver disease. J Paediatr Child Health. 2007;43:414.
14. Davis JN, Le KA, Walker RW, et al. Increased hepatic fat in overweight Hispanic youth influenced by interaction between genetic variation in PNPLA3 and high dietary carbohydrate and sugar consumption. Am J Clin Nutr. 2010;92:1522-1527.
15. Lavine JE. Vitamin E treatment of nonalcoholic steatohepatitis in children: a pilot study. J Pediatr. 2000;136:734-738.
16. Sanyal AJ, Chalasani N, Kowdley KV, et al. Pioglitazone, vitamin E or placebo for nonalcoholic steatohepatitis. N Engl J Med. 2010;362:1675-1685.
17. Lavine JE, Schwimmer JB, Van Natta ML, et al. Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents. JAMA. 2011;305:1659-1668.
18. Vajro P, Franzese A, Valerio G, et al. Lack of efficacy of ursodeoxycholic acid for the treatment of liver abnormalities in obese children. J Pediatr. 2000;136:739-743.